Skip to main content
Erschienen in: Digestive Diseases and Sciences 3/2007

01.03.2007 | Case Report

Large Cell Lymphoma Presenting as a Flare of Colitis in a Patient with Common Variable Immune Deficiency

verfasst von: Megan Dunnigan, Harris Yfantis, Aaron P. Rapoport, Keya Hosseinzadeh, Christopher D. Gocke, Raymond K. Cross

Erschienen in: Digestive Diseases and Sciences | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Excerpt

Common variable immune deficiency (CVID) is one of the most common primary immunodeficiencies, with an incidence worldwide ranging from 1 in 25,000 to 1 in 100,000 [1]. CVID is found equally among men and women and has a bimodal age distribution with peaks occurring between 1 and 5 years and between 18 and 25 years of age [2]. The pathogenesis is not well understood; however, defects exist in B-cell differentiation [3, 4], T-cell function and signaling [57], and immunoglobulin secretion [8]. The multiple immune defects present in CVID lead to a myriad of clinical symptoms including recurrent sinopulmonary infections, chronic lung disease, autoimmune diseases, liver and gastrointestinal disorders, lymphomas, and solid organ tumors [4, 9, 10]. …
Literatur
1.
Zurück zum Zitat Hammarstrom L, Vorechovsky I, Webster D (2000) Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 120:225–231PubMedCrossRef Hammarstrom L, Vorechovsky I, Webster D (2000) Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 120:225–231PubMedCrossRef
2.
Zurück zum Zitat Hermaszewski RA, Webster AD (1993) Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 86:31–42PubMed Hermaszewski RA, Webster AD (1993) Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 86:31–42PubMed
3.
Zurück zum Zitat Saiki O, Ralph P, Cunningham-Rundles C, et al. (1982) Three distinct stages of B-cell defects in common varied immunodeficiency. Proc Natl Acad Sci USA 79:6008–6012PubMedCrossRef Saiki O, Ralph P, Cunningham-Rundles C, et al. (1982) Three distinct stages of B-cell defects in common varied immunodeficiency. Proc Natl Acad Sci USA 79:6008–6012PubMedCrossRef
4.
Zurück zum Zitat Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34–48PubMedCrossRef Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34–48PubMedCrossRef
5.
Zurück zum Zitat Cunningham-Rundles S, Cunningham-Rundles C, Siegal FP, et al. (1981) Defective cellular immune response in vitro in common variable immunodeficiency. J Clin Immunol 65–72 Cunningham-Rundles S, Cunningham-Rundles C, Siegal FP, et al. (1981) Defective cellular immune response in vitro in common variable immunodeficiency. J Clin Immunol 65–72
6.
Zurück zum Zitat Stagg AJ, Funauchi M, Knight SC, et al. (1994) Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol 96:48–53PubMedCrossRef Stagg AJ, Funauchi M, Knight SC, et al. (1994) Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol 96:48–53PubMedCrossRef
7.
Zurück zum Zitat Kondratenko I, Amlot PL, Webster AD, et al. (1997) Lack of specific antibody response in common variable immunodeficiency (CVID) associated with failure in production of antigen-specific memory T cells. MRC Immunodeficiency Group. Clin Exp Immunol 108:9–13PubMedCrossRef Kondratenko I, Amlot PL, Webster AD, et al. (1997) Lack of specific antibody response in common variable immunodeficiency (CVID) associated with failure in production of antigen-specific memory T cells. MRC Immunodeficiency Group. Clin Exp Immunol 108:9–13PubMedCrossRef
8.
Zurück zum Zitat Bryant A, Calver NC, Toubi E, et al. (1990) Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin Immunol Immunopathol 56:239–248PubMedCrossRef Bryant A, Calver NC, Toubi E, et al. (1990) Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin Immunol Immunopathol 56:239–248PubMedCrossRef
9.
Zurück zum Zitat Cunningham-Rundles C (1989) Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol 9:22–33PubMedCrossRef Cunningham-Rundles C (1989) Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol 9:22–33PubMedCrossRef
10.
Zurück zum Zitat Sneller MC, Strober W, Eisenstein E, et al. (1993) NIH conference. New insights into common variable immunodeficiency. Ann Intern Med 118:720–730PubMed Sneller MC, Strober W, Eisenstein E, et al. (1993) NIH conference. New insights into common variable immunodeficiency. Ann Intern Med 118:720–730PubMed
11.
Zurück zum Zitat Washington K, Stenzel TT, Buckley RH, et al. (1996) Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol 20:1240–1252PubMedCrossRef Washington K, Stenzel TT, Buckley RH, et al. (1996) Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol 20:1240–1252PubMedCrossRef
12.
Zurück zum Zitat Lai Ping So A, Mayer L (1997) Gastrointestinal manifestations of primary immunodeficiency disorders. Semin Gastrointest Dis 8:22–32PubMed Lai Ping So A, Mayer L (1997) Gastrointestinal manifestations of primary immunodeficiency disorders. Semin Gastrointest Dis 8:22–32PubMed
13.
Zurück zum Zitat Kutukculer N, Yagci RV, Aydogdu S, et al. (2001) Chronic inflammatory bowel disease in a patient with common variable immunodeficiency. Turk J Pediatr 43:88–90PubMed Kutukculer N, Yagci RV, Aydogdu S, et al. (2001) Chronic inflammatory bowel disease in a patient with common variable immunodeficiency. Turk J Pediatr 43:88–90PubMed
14.
Zurück zum Zitat Feugier P, Van Hoof A, Sebban C, et al. (2005) Long-term results of the R-CHOP Study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol 23:4117–4126PubMedCrossRef Feugier P, Van Hoof A, Sebban C, et al. (2005) Long-term results of the R-CHOP Study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol 23:4117–4126PubMedCrossRef
15.
Zurück zum Zitat Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, et al. (1987) Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol 7:294–299PubMedCrossRef Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, et al. (1987) Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol 7:294–299PubMedCrossRef
16.
Zurück zum Zitat Bernstein CN, Blanchard JF, Kliewer E, et al. (2001) Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91:854–862PubMedCrossRef Bernstein CN, Blanchard JF, Kliewer E, et al. (2001) Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91:854–862PubMedCrossRef
17.
Zurück zum Zitat Palli D, Trallori G, Bagnoli S, et al. (2000) Hodgkin's disease risk is increased in patients with ulcerative colitis. Gastroenterology 119:647–653PubMedCrossRef Palli D, Trallori G, Bagnoli S, et al. (2000) Hodgkin's disease risk is increased in patients with ulcerative colitis. Gastroenterology 119:647–653PubMedCrossRef
18.
Zurück zum Zitat Farrell RJ, Ang Y, Kileen P, et al. (2000) Increased incidence of non–Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut 47:514–519PubMedCrossRef Farrell RJ, Ang Y, Kileen P, et al. (2000) Increased incidence of non–Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut 47:514–519PubMedCrossRef
19.
Zurück zum Zitat Arseneau KO, Stukenborg GJ, Connors AF Jr, et al. (2001) The incidence of lymphoid and myeloid malignancies among hospitalized Crohn's disease patients. Inflamm Bowel Dis 7:106–112PubMedCrossRef Arseneau KO, Stukenborg GJ, Connors AF Jr, et al. (2001) The incidence of lymphoid and myeloid malignancies among hospitalized Crohn's disease patients. Inflamm Bowel Dis 7:106–112PubMedCrossRef
20.
Zurück zum Zitat Loftus EV Jr, Tremaine WJ, Habermann TM, et al. (2000) Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol 95:2308–2312PubMedCrossRef Loftus EV Jr, Tremaine WJ, Habermann TM, et al. (2000) Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol 95:2308–2312PubMedCrossRef
21.
Zurück zum Zitat Lewis JD, Bilker WB, Brensinger C, et al. (2001) Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 121:1080–1087PubMedCrossRef Lewis JD, Bilker WB, Brensinger C, et al. (2001) Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 121:1080–1087PubMedCrossRef
22.
Zurück zum Zitat Askling J, Brandt L, Lapidus A, et al. (2005) Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 54:617–622PubMedCrossRef Askling J, Brandt L, Lapidus A, et al. (2005) Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 54:617–622PubMedCrossRef
Metadaten
Titel
Large Cell Lymphoma Presenting as a Flare of Colitis in a Patient with Common Variable Immune Deficiency
verfasst von
Megan Dunnigan
Harris Yfantis
Aaron P. Rapoport
Keya Hosseinzadeh
Christopher D. Gocke
Raymond K. Cross
Publikationsdatum
01.03.2007
Erschienen in
Digestive Diseases and Sciences / Ausgabe 3/2007
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9299-6

Weitere Artikel der Ausgabe 3/2007

Digestive Diseases and Sciences 3/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.